By Alajuela, Costa Rica — AVNA Inc., a leader in advanced manufacturing and medical devices, has officially opened its new operations center in Evolution Free Zone, Grecia, Alajuela, Costa Rica. Representing a $5.5 million investment and a 116% expansion of production capacity, the new facility anchors Evolution Free Zone and underscores AVNA’s commitment to innovation and growth in Costa Rica.
The 5,900-square-meter plant dedicates 5,200 square meters to production and 700 square meters to administrative operations. This expansion will enable AVNA to incorporate advanced technologies such as laser cutting, marking, and welding, plastic injection molding, precision grinding, CNC machining, automation, and advanced assemblies.
To gain deeper insights into the legal intricacies surrounding foreign investment in Costa Rica, TicosLand.com spoke with Lic. Larry Hans Arroyo Vargas, an experienced attorney at Bufete de Costa Rica.
Foreign investment in Costa Rica offers significant opportunities, but navigating the legal landscape is crucial. Due diligence is paramount, particularly regarding property ownership, corporate structuring, and compliance with evolving regulations. Investors should seek expert legal counsel to mitigate risks and maximize the potential of their ventures.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Lic. Arroyo Vargas’s emphasis on due diligence and legal counsel is crucial for navigating the complexities of foreign investment in Costa Rica. Understanding the nuances of property rights, corporate structures, and the ever-changing regulatory environment can truly make or break a venture. We thank Lic. Larry Hans Arroyo Vargas for providing this valuable perspective, reminding potential investors that informed decisions are the cornerstone of successful investment in Costa Rica.
Choosing Costa Rica as a key location for AVNA’s growth was a strategic decision driven by our clients’ needs and the country’s ability to foster mutually beneficial business partnerships that optimize the supply chain, quality, and advancement of technologies that improve quality of life.
Jason Howey, CEO of AVNA
The selection of Costa Rica reflects the country’s robust talent pool and supportive business environment. Howey further emphasized the alignment between AVNA’s commitment to excellence and technological advancement with the innovative mindset of Costa Rican professionals.
The country is home to a large group of talented professionals with an innovative mindset, which aligns perfectly with our commitment to excellence and technological advancement. In addition, Costa Rica’s strong sense of community and its ability to provide a high quality of life for our employees reinforces our conviction that this is the ideal place to expand and bring value to our clients and the local community.
Jason Howey, CEO of AVNA
AVNA’s Vice President of Operations, Mario Chaves, highlighted the company’s 13-year presence in Costa Rica, noting its evolution towards more complex operations integrating advanced automation, data-driven decision making, and collaboration with global teams. This growth aligns with AVNA’s 2024 adoption of the name “Advanced Innovation.”
We have more than 13 years of presence in Costa Rica and I can attest to our evolution towards a more complex operation, integrating advanced automation, data-driven decision making, and collaboration with global teams; a growth of the organization that perfectly aligns with the adoption of the name AVNA “Advanced Innovation”, which we carried out in 2024.
Mario Chaves, Vice President of Operations, AVNA
Costa Rica continues to solidify its position as a key destination for foreign investment in advanced manufacturing and medical devices. With 14 of the top 30 life sciences multinationals operating in the country, AVNA’s expansion serves as a testament to investor confidence in Costa Rican talent and the favorable business climate.
We have been with AVNA since its beginnings in Costa Rica, more than 13 years ago, so we are clear about its evolutionary process in the country, which today allows us to celebrate this important growth that will strengthen its vision to continue providing innovative solutions to the sector and strengthen its presence in the region.
Fernando Cruz, President of CINDE
Currently employing 150 people in Costa Rica, AVNA projects the creation of approximately 200 new jobs in engineering, manufacturing, automation, and quality control over the next three years. The company’s Costa Rican plant has been recognized with the Innovation and Technology Excellence Award for its manufacture of titanium micro-implants used in oncological treatments and has been lauded for its commitment to economic and social development, supporting initiatives that improve quality of life in the communities where it operates.
For further information, visit avna-med.com
About AVNA:
AVNA Inc. is a leader in advanced manufacturing and medical devices, specializing in innovative solutions for various industries, including healthcare. The company is committed to technological advancement and quality, partnering with clients to optimize their supply chains and improve product quality.
For further information, visit cinde.org
About CINDE:
The Costa Rican Investment Promotion Agency (CINDE) is a private, non-profit organization responsible for attracting foreign direct investment into Costa Rica. CINDE works closely with companies to facilitate their establishment and growth in the country.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Bufete de Costa Rica distinguishes itself as a leading legal institution dedicated to the highest ethical standards and the pursuit of legal excellence. Through a history of innovative solutions and a client-focused approach across various industries, the firm consistently strives to empower individuals and communities. By championing accessible legal education and resources, Bufete de Costa Rica reinforces its core belief in a society strengthened by knowledge and understanding of the law.
